Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-03-31
1996-10-29
Azpuru, Carlos
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424423, 43524022, 514964, 6048901, 6048921, 623 11, A61F 202, A61K 922, C12N 502
Patent
active
055694624
ABSTRACT:
Methods for enhancing vascular support of cells housed within an implanted apparatus are disclosed. The methods comprise placing a population of therapeutic substance-producing cells into the cell receiving chamber of an immunoisolation apparatus, implanting the apparatus into a patient, and administering an immunomodulatory agent to the patient. The immunomodulatory agent increases the number of close vascular structures in the vicinity of the implanted device, which increases the long term survival of the cell population housed therein.
REFERENCES:
patent: 3093831 (1963-06-01), Jordan
patent: 3313289 (1967-04-01), Kapral
patent: 3646616 (1972-03-01), Keshin
patent: 3699956 (1972-10-01), Kitrilakis et al.
patent: 3967618 (1976-07-01), Zaffaroni
patent: 3993072 (1976-11-01), Zaffaroni
patent: 4011861 (1977-03-01), Enger
patent: 4069307 (1978-01-01), Higuchi et al.
patent: 4180560 (1979-12-01), Katz et al.
patent: 4192308 (1980-03-01), Michaels
patent: 4207390 (1980-06-01), Oehrlein et al.
patent: 4217664 (1980-08-01), Faso
patent: 4266999 (1981-05-01), Baier
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4306318 (1981-12-01), Mano et al.
patent: 4309776 (1982-01-01), Berguer
patent: 4309996 (1982-01-01), Theeuwes
patent: 4352883 (1982-10-01), Lim
patent: 4352888 (1982-10-01), Sefton
patent: 4353888 (1982-10-01), Sefton
patent: 4368737 (1983-01-01), Ash
patent: 4374669 (1983-02-01), MacGregor
patent: 4378016 (1983-03-01), Loeb
patent: 4391909 (1983-07-01), Lim
patent: 4413359 (1983-11-01), Akiyama et al.
patent: 4475916 (1984-10-01), Hinnelstein
patent: 4505277 (1985-03-01), Klesius et al.
patent: 4508113 (1985-04-01), Malaney
patent: 4542539 (1985-09-01), Rowe, Jr. et al.
patent: 4553272 (1985-11-01), Mears
patent: 4557724 (1985-12-01), Gregonis et al.
patent: 4576608 (1986-03-01), Homsy
patent: 4597765 (1986-07-01), Klatt
patent: 4601893 (1986-07-01), Cardinal
patent: 4624847 (1986-11-01), Ayer et al.
patent: 4657544 (1987-04-01), Pinchuk
patent: 4664669 (1987-05-01), Ohyabu et al.
patent: 4670286 (1987-06-01), Nyilas et al.
patent: 4673566 (1987-06-01), Goosen et al.
patent: 4681582 (1987-07-01), Yamamoto
patent: 4684524 (1987-08-01), Eckenhoff et al.
patent: 4685447 (1987-08-01), Iversen et al.
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4687481 (1987-08-01), Nuwayser
patent: 4689293 (1987-08-01), Goosen et al.
patent: 4712553 (1987-12-01), MacGregor
patent: 4723947 (1988-02-01), Konopka
patent: 4743252 (1988-05-01), Martin, Jr. et al.
patent: 4795459 (1989-01-01), Jauregui
patent: 4798585 (1989-01-01), Inoue et al.
patent: 4803168 (1989-02-01), Jarvis, Jr.
patent: 4804381 (1989-02-01), Turina et al.
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4816339 (1989-03-01), Tu et al.
patent: 4826480 (1989-05-01), Diaz et al.
patent: 4855141 (1989-08-01), Eckenhoff et al.
patent: 4871366 (1989-10-01), von Recum et al.
patent: 4871542 (1989-10-01), Vilhardt
patent: 4877029 (1989-10-01), Valentini et al.
patent: 4878895 (1989-11-01), Klesius et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4880006 (1989-11-01), Albrektsson et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4911717 (1990-03-01), Gaskill, III
patent: 4922926 (1990-05-01), Hirschberg et al.
patent: 4936317 (1990-06-01), MacGregor
patent: 4937196 (1990-06-01), Wrasidlo
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4990138 (1991-02-01), Bacich et al.
patent: 5002661 (1991-03-01), Chick et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5015476 (1991-05-01), Cochrum et al.
patent: 5024670 (1991-06-01), Smith et al.
patent: 5077215 (1991-12-01), McAuslan et al.
patent: 5100392 (1992-03-01), Orth et al.
patent: 5112614 (1992-05-01), Magruder et al.
patent: 5156623 (1992-10-01), Hakamatsuka et al.
patent: 5201728 (1993-04-01), Giampapa
patent: 5213574 (1993-05-01), Tucker
patent: 5219361 (1993-06-01), von Recum et al.
patent: 5262055 (1993-11-01), Bae et al.
patent: 5324518 (1994-06-01), Orth et al.
patent: 5326568 (1994-07-01), Giampapa
patent: 5344454 (1994-09-01), Clarke et al.
Anderson, James M.: "Inflammatory Response to Implants," Trans. Am. Soc. Artif. Intern. Organs, vol. XXXIV, 1988, pp. 101-107.
Campbell, Craig E. and von Recum, Andreas F.: "Microtopography and Soft Tissue Response," Journal of Investigative Surgery, vol. 2, 1989, pp. 51-74.
Christenson, L. et al.: "Tissue Reaction to Intraperitoneal Polymer Implants: Species Difference and Effects of Corticaid and Doxorubicin," Journal of Biomedical Materials Research, vol. 23, 1989, pp. 705-718.
Colton et al.: "Bioengineering in Development of the Hybrid Artificial Pancreas," Transactions of the ASME, vol. 113, May 1991.
Klomp, Gregory F. et al.: "Macroporous Hydrogel Membranes for a Hybrid Artificial Pancreas," Journal of Biomedical Materials Research, vol. 17, 1983 pp. 865-871.
Knighton, David R. and Fiegel, Vance D.: "Macrophage-derived Growth Factors in Wound Healing," Am. Rev. Respir. Dis., 140, 1989, pp. 1108-1111.
Knighton, David R. et al.: "Oxygen Tension Regulates the Expression of Angiogenesis Factor by Macrophages," Science, Sep., 1981.
Lanza, Robert P. "Islet Transplantation With Immunoisolation" in Diabetes, vol. 41, Dec. 1992, pp. 1503-1510.
Menger, M. D. et al. "The Influence of Cyclosporine on the Microvasculature of Xenogeic Pancreatic Islet Grafts" in Transplantation Proceedings, vol. 23, Aug. 1991, pp. 2217-2218.
Miller, K. M. et al.: "Characterization of Biomedical Polymer Adherent Machrophages: Interleukin 1 Generation and Scanning Electron Microscopy Studies," Biomaterials, vol. 10, Apr. 1989, pp. 187-196.
Polverini et al.: "Activated Macrophages Induce Vascular Proliferation," Nature, vol. 269, Oct. 27, 1977, pp. 804-806.
Rooth, Pal et al. "Prevention of Detrimental Effect of Cyclosporin A on Vascular Ingrowth of Transplanted Pancreatic Islets With Verapamil" in Diabetes, vol. 38, Suppl. 1, Jan. 1989, pp. 202-205.
Scharp, David W. et al.: "Islet Immuno-Isolation: The Use of Hybrid Artificial Organs to Prevent Islet Tissue Rejection",: World Journal of Surgery, 1984, pp. 221-229.
Schmidt, J. A. and von Recum, A. F.: "Texturing of Polymer Surfaces at the Cellular Level," Biomaterials, vol. 12, 1991, pp. 385-389.
Woodward, Stephen C. and Salthouse, Thomas N.: "The Tissue Response to Implants and Its Evaluation by Light Microscopy," Handbook of Biomaterials Evaluation, pp. 364-378.
Rooth et al. (1989), "Prevention of Detrimental Effect of Cyclosporin A on Vascular Ingrowth of Transplanted Pancreatic Islets With Verapamil," Diabetes, vol. 38, pp. 202-205.
Menger et al. (1991), "The Influence of Cyclosporine on the Microvasculature of Xenogenic Pancreatic Islet Grafts," Transplantation Proceedings, vol. 23, 2217-2218.
Lanza, Robert P. (1992), "Islet Transplantation With Immunoisolation," Diabetes, vol. 41, pp. 1503-1510.
Langer and Vacanti (1993), "Tissue Engineering," Science, vol. 260, pp. 920-925.
Anderson, W. (1992), "Human Gene Therapy," Science, vol. 256, pp. 808-813.
Anderson, J. (1988), "Inflammatory Response to Implants," J. Trans. Am. Soc. Artif. Intern. Organs, vol 34, pp. 101-107.
Carotenuto et al. (1992), European Assoc. Study Diabetes, 28th Annual Meeting, Abstract 730.
Schreiber and Crabtree (1992), "The Mechanism of Action of Cyclosporin A and FK506," Immunol. Today, vol. 13, pp. 136-142.
Golumbek et al. (1991), "Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4," Science, vol 254, pp. 713-716.
Townsend and Alison (1993), "Tumor Rejection After Direct Costimulation of CD8.sup.30 T Cells by B7-Transfected Melanoma Cells," Science, vol. 259, pp. 368-370.
Trojan et al. (1993), "Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA," Science, vol. 259, pp. 94-97.
Scharp et al. (1984), "Islet Immuno-isolation: The Use of Hybrid Artificial Organs to Prevent Islet Tissue Rejection," World J. Surg., vol. 8, pp. 221-229.
Brauker James H.
Johnson Robert C.
Loudovaris Thomas
Martinson Laura A.
Azpuru Carlos
Baxter International Inc.
LandOfFree
Methods for enhancing vascularization of implant devices does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for enhancing vascularization of implant devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancing vascularization of implant devices will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784348